<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00155909</url>
  </required_header>
  <id_info>
    <org_study_id>9261700803</org_study_id>
    <secondary_id>NTUH-92N013</secondary_id>
    <nct_id>NCT00155909</nct_id>
  </id_info>
  <brief_title>Risk Factors of Radiation Pneumonitis</brief_title>
  <official_title>To Investigate Risk Factors of Radiation Pneumonitis, Fibrosis, and Impairment of Quality of Life by Radiotherapeutic Dosimetric and Biological Parameters for Lung Cancer Patients Receiving Thoracic Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      A prospective observational study to evaluate clinical, dosimetrical, functional, and&#xD;
      biological factors in predicting radiation pneumonitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We propose a prospective observational study to investigate the combinational effect of&#xD;
      radiotherapeutic dosimetric parameters [mean lung dose &amp; percentage of lung volume receiving&#xD;
      at least 20Gy (V20)] and biological parameters [interleukin-6(IL6) &amp; transforming growth&#xD;
      factor beta (TGFB)] in predicting radiation pneumonitis, fibrosis, and change of QoL among at&#xD;
      least fifty-three lung cancer patients. Eligibility included pathological or cytological&#xD;
      proven small cell or non small cell lung cancer, thoracic RT planned for more than 30Gy [if&#xD;
      fraction size &gt;= 3Gy/fx] or 40Gy [if fraction size &lt; 3 Gy/Fx], ECOG performance status [PS]&#xD;
      0-2, body weight loss [BWL] &lt;=10% in previous 6 months, no prior thoracic RT and signed&#xD;
      informed consent prior to study entry. Basic pre-radiotherapy information will be collected,&#xD;
      which included BWL, ECOG PS, AJCC stage [I-IV], primary lesion site, history of&#xD;
      smoking/coexisting lung disease/dosage of chemotherapy/surgical resection, albumin level, and&#xD;
      pulmonary function test of FEV1/VC/DLCO(optional). Computed tomography [CT] of the whole lung&#xD;
      in treatment position with reference mark will be done for calculation of V20 and mean lung&#xD;
      dose. Blood test of IL6, TGFB by ELISA will be done before and after RT after storage at&#xD;
      -80â„ƒ. Bronchial-alveolar lavage test of IL6, TGFB by ELISA will be done before and after RT&#xD;
      if clinical available. Self-reported questionnaire [EORTC C30 &amp; L13] will be collected before&#xD;
      and after RT and in every follow up visits after double-checked by trained assistants. RT&#xD;
      must be given by photon energies &gt;=6MV. Radiation pneumonitis and fibrosis will be assessed&#xD;
      according to common toxicity criteria 3 [CTC-3] weekly during RT and in every follow up&#xD;
      visits. Chi-square test, logistic regression, and proportional hazard ratio method will be&#xD;
      used to investigate whether the parameter(s) can be effective in predicting radiation related&#xD;
      sequelae.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2003</start_date>
  <completion_date>June 2006</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment>53</enrollment>
  <condition>Radiation Pneumonitis</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Non-pregnant adults (age &gt;=20 y/o)&#xD;
&#xD;
          -  Pathological or cytological proven small cell or non small cell lung cancer&#xD;
&#xD;
          -  Thoracic RT planned for more than 30Gy [if fraction size &gt;= 3Gy/fx] or 40Gy [if&#xD;
             fraction size &lt; 3 Gy/Fx]&#xD;
&#xD;
          -  ECOG PS 0-2&#xD;
&#xD;
          -  Body weight loss &lt;=10% in previous 6 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  prior thoracic RT&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chun-Ru Chien, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chun-Ru Chien, M.D.</last_name>
    <phone>886-2-23123456</phone>
    <phone_ext>2643</phone_ext>
    <email>stwo@ha.mc.ntu.edu.tw</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wei-Chu Chie, M.D.and PhD</last_name>
    <phone>886-2-23516478</phone>
    <phone_ext>26</phone_ext>
    <email>weichu@episerv.cph.ntu.edu.tw</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chun-Ru Chien, MD</last_name>
      <phone>886-23123456</phone>
      <phone_ext>2643</phone_ext>
      <email>stwo@ha.mc.ntu.edu.tw</email>
    </contact>
    <contact_backup>
      <last_name>Wei Chu Chie, M.D., Ph.D.</last_name>
      <phone>886-2-23516478</phone>
      <phone_ext>26</phone_ext>
      <email>weichu@episerv.cph.ntu.edu.tw</email>
    </contact_backup>
    <investigator>
      <last_name>Chun-Ru Chien, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>June 2005</verification_date>
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>November 22, 2005</last_update_submitted>
  <last_update_submitted_qc>November 22, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 23, 2005</last_update_posted>
  <keyword>Radiation Pneumonitis</keyword>
  <keyword>Radiotherapy Planning, Computer-Assisted</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Radiation Pneumonitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

